Xbrane Biopharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2022-08-17 | Xbrane Biopharma AB | Maria Edebrink | Other senior executive | Acquisition | 118 | 84,9 | SEK | 10 018,2 | 2022-08-15 |
| 2022-08-19 | Xbrane Biopharma AB | Maria Edebrink | Other senior executive | Acquisition | 500 | 86,8 | SEK | 43 400 | 2022-08-16 |
| 2022-08-19 | Xbrane Biopharma AB | Maria Edebrink | Other senior executive | Acquisition | 1 000 | 86,9 | SEK | 86 900 | 2022-08-16 |
| 2022-08-19 | Xbrane Biopharma AB | Maria Edebrink | Other senior executive | Acquisition | 1 000 | 87,1 | SEK | 87 100 | 2022-08-16 |
| 2022-08-19 | Xbrane Biopharma AB | Maria Edebrink | Other senior executive | Acquisition | 500 | 86,692 | SEK | 43 346 | 2022-08-16 |
| 2022-08-19 | Xbrane Biopharma AB | Maria Edebrink | Other senior executive | Acquisition | 742 | 86,947 | SEK | 64 514,674 | 2022-08-16 |
| 2022-08-19 | Xbrane Biopharma AB | David Vikström | Other member of the company's administrative, management or supervisory body | Acquisition | 1 500 | 84 | SEK | 126 000 | 2022-08-17 |
| 2022-08-19 | Xbrane Biopharma AB | David Vikström | Other member of the company's administrative, management or supervisory body | Acquisition | 500 | 81,85 | SEK | 40 925 | 2022-08-18 |
| 2022-11-10 | Xbrane Biopharma AB | Anette Lindqvist | Chief Financial Officer (CFO) | Acquisition | 1 000 | 70,1 | SEK | 70 100 | 2022-11-09 |
| 2022-12-15 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 2 186 | 79,9 | SEK | 174 661,4 | 2022-12-14 |
| 2022-12-23 | Xbrane Biopharma AB | Maria Edebrink | Other senior executive | Acquisition | 2 000 | 77,96 | SEK | 155 920 | 2022-12-22 |
| 2022-12-29 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 1 390 | 75 | SEK | 104 250 | 2022-12-27 |
| 2022-12-30 | Xbrane Biopharma AB | Anette Lindqvist | Chief Financial Officer (CFO) | Acquisition | 1 000 | 78,382 | SEK | 78 381,5 | 2022-12-29 |
| 2023-02-20 | Xbrane Biopharma AB | Anette Lindqvist | Chief Financial Officer (CFO) | Acquisition | 500 | 93 | SEK | 46 500 | 2023-02-16 |
| 2023-02-21 | Xbrane Biopharma AB | Anette Lindqvist | Chief Financial Officer (CFO) | Acquisition | 500 | 90 | SEK | 45 000 | 2023-02-19 |
| 2023-06-01 | Xbrane Biopharma AB | Anette Lindqvist | Chief Financial Officer (CFO) | Acquisition | 3 000 | 78,8 | SEK | 236 400 | 2023-05-31 |
| 2023-06-12 | Xbrane Biopharma AB | Siavash Bashiri | Deputy CEO/Deputy Managing Director | Acquisition | 870 | 80 | SEK | 69 600 | 2023-06-11 |
| 2023-06-12 | Xbrane Biopharma AB | Siavash Bashiri | Deputy CEO/Deputy Managing Director | Disposal | 9 400 | 79,5 | SEK | 747 300 | 2023-06-11 |
| 2023-06-12 | Xbrane Biopharma AB | Siavash Bashiri | Deputy CEO/Deputy Managing Director | Disposal | 870 | 80 | SEK | 69 600 | 2023-06-11 |
| 2023-06-12 | Xbrane Biopharma AB | Siavash Bashiri | Deputy CEO/Deputy Managing Director | Acquisition | 9 400 | 79,5 | SEK | 747 300 | 2023-06-11 |